Mylan Laboratories Limited Valsartan Export Data — India (DGFT 2022–2026)

Name: Mylan Laboratories Limited Valsartan Export Records India — #1 Exporter, 578 Shipments, $28.9M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Valsartan

India Pharmaceutical Trade Intelligence

$196.9M259 Suppliers119 CountriesHS 30049079

ExportsIndia → UNITED STATES60.8%India → GERMANY6.2%

ImportsITALY → India$280.6B BULGARIA → India$7.2M

#1 Supplier: MYLAN LABORATORIES #1 Buyer: MYLAN PHARMACEUTICALS

Mylan Laboratories Limited — Valsartan Exporter #1 | $28.9M Trade Value | TransData Nexus | TransData Nexus

Mylan Laboratories Limited — Valsartan Exporter Profile

Indian Pharmaceutical Exporter · #1 for Valsartan · $28.9M export value · DGFT Verified

Mylan Laboratories Limited is the #1 Indian exporter of Valsartan with $28.9M in export value and 578 verified shipments. Mylan Laboratories Limited holds a 14.7% market share in Valsartan exports across 14 countries. The company exports 91 pharmaceutical products worth $634.8M across 26 therapeutic categories.

Mylan Laboratories Limited — Valsartan Export Profile: Buyers & Destinations

Mylan Laboratories Limited Valsartan export treemap — buyers and destination countries | TransData Nexus

Where Does Mylan Laboratories Limited Export Valsartan?

Country	Value	Shipments	Share
UNITED STATES	$9.4M	209	51.5%
HUNGARY	$4.7M	132	25.7%
FRANCE	$2.4M	75	13.1%
NETHERLANDS	$1.0M	76	5.6%

Who Are the Top Buyers of Valsartan from Mylan Laboratories Limited?

Buyer	Country	Value	Orders
MYLAN PHARMACEUTICALS INC,	UNITED STATES	$4.1M	93
MYLAN PHARMACEUTICALS INC	UNITED STATES	$3.2M	69
MYLAN HUNGARY KFT,	HUNGARY	$3.1M	90
M/S. MYLAN PHARMACEUTICALS INC,	UNITED STATES	$1.5M	31
MYLAN HUNGARY KFT	HUNGARY	$742.8K	18
MYLAN HUNGARY KFT MYLAN U	HUNGARY	$685.9K	19
MYLANPHARMACEUTICALS INC	UNITED STATES	$564.1K	12
M/S. CSP MYLAN SAS AT CSP LABO 274	FRANCE	$538.1K	12
VIATRIS HEALTHCARE GMBH	GERMANY	$498.6K	23
CSP MYLAN SAS AT CSP LABO 274	FRANCE	$436.3K	13

Mylan Laboratories Limited supplies Valsartan to 63 buyers globally. The largest buyer is MYLAN PHARMACEUTICALS INC, (UNITED STATES), followed by MYLAN PHARMACEUTICALS INC (UNITED STATES) and MYLAN HUNGARY KFT, (HUNGARY). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Valsartan Formulations Does Mylan Laboratories Limited Export?

Product Description / Formulation	Value	Shipments
VALSARTAN AND HYDROCHLOROTHIAZIDE TABLET	$2.8M	61
AMLODIPINE AND VALSARTAN TABLETS USP 10M	$565.6K	13
AMLODIPINE AND VALSARTAN TABLETS USP 10	$533.8K	11
AMLODIPINE AND VALSARTAN TABLETS USP 5MG	$442.4K	9
AMLODIPINE AND VALSARTAN TABLETS USP 5 M	$340.0K	7
AMLODIPINE / VALSARTAN MYLAN 5 MG / 80 M	$313.9K	10
AMLODIPINE/VALSARTAN MYLAN 10 MG/160 MG	$252.7K	6
HARMLESS MEDICINES, VALSARTAN CAPSULES 1	$200.0K	4
AMLODIPINE / VALSARTAN MYLAN 10 MG / 160	$152.5K	4
VALSARTAN TABLETS USP 160 MG 90BT TAB PA	$150.0K	3

Mylan Laboratories Limited exports 329 distinct Valsartan formulations including tablets, capsules, syrups, and combination drugs. The top formulation is VALSARTAN AND HYDROCHLOROTHIAZIDE TABLET with 61 shipments worth $2.8M. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Mylan Laboratories Limited Compare to Nearest Valsartan Exporters?

Exporters ranked immediately above and below #1 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	MYLAN LABORATORIES LIMITED ★	$28.9M	578	14	$50.0K
2	MACLEODS PHARMACEUTICALS LTD	$27.9M	558	32	$50.0K
4	ALEMBIC PHARMACEUTICALS LIMITED	$10.5M	270	6	$38.8K

Mylan Laboratories Limited ranks #1 among 259 Indian Valsartan exporters. Average shipment value of $50.0K compared to the market average of $438.5K. The closest competitors by value are MACLEODS PHARMACEUTICALS LTD and ALEMBIC PHARMACEUTICALS LIMITED.

Which Indian Ports Ship Valsartan Exports?

Port	Shipments	% Share
SAHAR AIR	946	15.5%
SAHAR AIR CARGO ACC (INBOM4)	707	11.6%
DELHI AIR CARGO ACC (INDEL4)	627	10.3%
DELHI AIR	516	8.5%
NHAVA SHEVA SEA (INNSA1)	445	7.3%
JNPT/ NHAVA SHEVA SEA	323	5.3%
JNPT	213	3.5%
MUNDRA SEA	176	2.9%

Geopolitical & Trade Policy Impact on Mylan Laboratories Limited's Valsartan Exports

Mylan's export operations are influenced by a complex geopolitical landscape. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, resulting in increased freight costs and extended transit times. Major shipping lines have implemented 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, directly impacting the cost structure for Indian pharmaceutical exporters like Mylan. Additionally, diversions around the Cape of Good Hope have further elongated delivery schedules, posing challenges to time-sensitive pharmaceutical shipments.

In the United States, the imposition of tariffs on pharmaceutical imports has prompted Indian companies to reassess their market strategies. While generics have largely remained exempt, the potential for future tariff expansions necessitates vigilance. Mylan, along with other Indian exporters, is exploring market diversification to mitigate reliance on the U.S. market. The recent India-European Union Free Trade Agreement (FTA), signed in January 2026, offers a strategic avenue for expansion. The FTA eliminates tariffs on approximately 97% of EU tariff lines, including pharmaceuticals, thereby enhancing market access for Indian exporters. This agreement is expected to significantly boost India's pharmaceutical exports to Europe, providing a counterbalance to uncertainties in the U.S. market.

Mylan Laboratories Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains paramount for Mylan. The FDA's warning letter and import alert in December 2024 concerning the Indore facility underscore the critical importance of stringent quality control measures. The cited violations, including subpar quality control and improper management of manufacturing defects, have necessitated comprehensive corrective actions. Mylan's proactive response aims to restore compliance and reinforce its commitment to quality assurance.

The evolving regulatory environment, particularly in the European Union, further emphasizes the need for adherence to Good Manufacturing Practices (GMP). The EU's Falsified Medicines Directive mandates rigorous compliance to ensure product integrity and patient safety. For Mylan, aligning with these standards is essential to maintain and expand its foothold in the European market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Valsartan shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Mylan Laboratories Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 578 individual customs records matching Mylan Laboratories Limited exporting Valsartan, covering 329 formulations to 14 countries via 63 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 119+ countries, 663+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Valsartan

Valsartan

Mylan Laboratories Limited — Valsartan Exporter Profile

Mylan Laboratories Limited — Valsartan Export Profile: Buyers & Destinations

Where Does Mylan Laboratories Limited Export Valsartan?

Who Are the Top Buyers of Valsartan from Mylan Laboratories Limited?

What Is India's Total Valsartan Export Value and How Much Does Mylan Laboratories Limited Contribute?

What Is the Average Shipment Value for Mylan Laboratories Limited's Valsartan Exports?

How Does Mylan Laboratories Limited Compare to Other Indian Valsartan Exporters?

What Valsartan Formulations Does Mylan Laboratories Limited Export?

Regulatory Requirements: Exporting Valsartan to Key Markets

United States — FDA

How Does Mylan Laboratories Limited Compare to Nearest Valsartan Exporters?

Which Indian Ports Ship Valsartan Exports?

What Other Cardiovascular Products Does Mylan Laboratories Limited Export?

Valsartan — Export Intelligence Video

Geopolitical & Trade Policy Impact on Mylan Laboratories Limited's Valsartan Exports

Mylan Laboratories Limited — Regulatory Compliance & Quality Standards

About Mylan Laboratories Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Valsartan Export Data from Mylan Laboratories Limited

Valsartan Stats

Company Overview

Top Products by Mylan Laboratories Limited

Related Analysis

Need Detailed Export Data?

Data Source